Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing

Clinical Reviews in Allergy and Immunology

Volumn 54, Issue 2, 2018, Pages 261-268

  Ameratunga, Rohan ^a   Lehnert, Klaus ^b   Woon, See Tarn ^a   Gillis, David ^c   Bryant, Vanessa L ^d,e,f   Slade, Charlotte A ^d,e,f   Steele, Richard ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

CVID; CVID like disorders; IVIG; NGS

Indexed keywords

COMMON VARIABLE IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY LIKE DISORDER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GENE DISCOVERY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNE DEFICIENCY; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; PHENOTYPE; REVIEW; WHOLE GENOME SEQUENCING; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; HIGH THROUGHPUT SEQUENCING; MUTATION; PROCEDURES;

COMMON VARIABLE IMMUNODEFICIENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; WHOLE GENOME SEQUENCING;

EID: 85031411730     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-017-8645-0     Document Type: Review

References (35)

1. Gathmann B, Mahlaoui N, Gerard L et al (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134(1):116–126
2. Chapel H, Lucas M, Lee M et al (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112(2):277–286
3. Ameratunga R, Becroft DM, Hunter W (2000) The simultaneous presentation of sarcoidosis and common variable immune deficiency. Pathology 32(4):280–282
4. Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R (2013) New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 174(2):203–211
5. Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R (2014) New diagnostic criteria for CVID. Expert Rev Clin Immunol 10(2):183–186
6. Koopmans W, Woon ST, Zeng IS et al (2013) Variability of memory B cell markers in a cohort of common variable immune deficiency patients over six months. Scand J Immunol 77(6):470–475
7. Ameratunga R, Barker R, Steele R et al (2015) Profound reversible hypogammaglobulinemia caused by celiac disease in the absence of protein losing enteropathy. J Clin Immunol 35(6):589–594
8. Ameratunga R, Lindsay K, Woon S-T, Jordan A, Anderson NE, Koopmans W (2015) New diagnostic criteria could distinguish common variable immunodeficiency disorder from anticonvulsant-induced hypogammaglobulinemia. Clin Exp Neuroimmunol 6(1):83–88
9. Ameratunga R, Storey P, Barker R, Jordan A, Koopmans W, Woon ST (2015) Application of diagnostic and treatment criteria for common variable immunodeficiency disorder. Expert Rev Clin Immunol 12(3):257–266
10. Ameratunga RV, Parry S, Kenedi C (2013) Hypogammaglobulinemia factitia- Munchausen syndrome presenting as common variable immune deficiency. Allergy Asthma Clin Immunol. 9(36)
11. Ameratunga R, Brewerton M, Slade C et al (2014) Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol 5:415
12. Bonilla FA, Barlan I, Chapel H et al (2016) International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4(1):38–59
13. Oksenhendler E, Gerard L, Fieschi C et al (2008) Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 46(10):1547–1554
14. Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93(3):190–197
15. Empson M, Sinclair J, O'Donnell J, Ameratunga R, Fitzharris P, Steele R (2004) The assessment and management of primary antibody deficiency. N Z Med J 117(1195):U914
16. Ameratunga R, Gillis D, Steele R (2016) Diagnostic criteria for common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 4(5):1017–1018
17. Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med: Off J Am Coll Med Genet 17(5):405–424
18. Woon ST, Ameratunga R. Comprehensive genetic testing for primary immunodeficiency disorders in a tertiary hospital: 10-year experience in Auckland, New Zealand. Allergy Asthma Clin Immunol 2016;12:65
19. Ameratunga R, Winkelstein JA, Brody L et al (1998) Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency. J Immunol 160(6):2824–2830
20. Bacchelli C, Buckland KF, Buckridge S et al (2011) The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. J Allergy Clin Immunol 127(5):1253–1259 e1213
21. Ameratunga R, Bartlett A, McCall J, Steele R, Woon ST, Katelaris CH (2016) Hereditary angioedema as a metabolic liver disorder: novel therapeutic options and prospects for cure. Front Immunol 7:547
22. Fliegauf ML, Bryant V, Frede N et al (2015) Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet 97(3):389–403
23. Bogaert DJ, Dullaers M, Lambrecht BN, Vermaelen KY, De Baere E, Haerynck F (2016) Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J Med Genet. 53(9):575–590. https://doi.org/10.1136/jmedgenet-2015-103690
24. Raje N, Soden S, Swanson D, Ciaccio CE, Kingsmore SF, Dinwiddie DL (2014) Utility of next generation sequencing in clinical primary immunodeficiencies. Curr Allergy Asthma Rep 14(10):468
25. Grimbacher B, Warnatz K, Yong PF, Korganow AS, Peter HH (2016) The crossroads of autoimmunity and immunodeficiency: lessons from polygenic traits and monogenic defects. J Allergy Clin Immunol 137(1):3–17 quiz 18
26. Ameratunga R, Woon ST, Brewerton M et al (2011) Primary immune deficiency disorders in the South Pacific: the clinical utility of a customized genetic testing program in New Zealand. Ann N Y Acad Sci 1238:53–64
27. Ameratunga R, Woon ST, Neas K, Love DR (2010) The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review. Allergy Asthma Clin Immunol 6(1):12
28. Ameratunga R, Steele R, Jordan A et al (2016) The case for a national service for primary immune deficiency disorders in New Zealand. N Z Med J. 129(1436):75–90
29. Ameratunga R, Woon ST (2009) Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country. N Z Med J 122(1304):46–53
30. Rodriguez-Cortez VC, Del Pino-Molina L, Rodriguez-Ubreva J et al (2015) Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naive-to-memory B-cell transition. Nat Commun 6:7335
31. van Schouwenburg PA, Davenport EE, Kienzler AK et al (2015) Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol 160(2):301–314
32. Kienzler AK, Hargreaves CE, Patel SY (2017) The role of genomics in common variable immunodeficiency disorders. Clin Exp Immunol 188(3):326–332
33. Ameratunga R, Koopmans W, Woon ST, et al. Epistatic interactions between mutations of TACI (TNFRS13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus. Clin Transl Immunol (Nature). 2017;(in press)
34. Bateson (1909) Discussion on the influence of heredity on disease, with special reference to tuberculosis, cancer, and diseases of the nervous system: introductory address. Proc R Soc Med;2(Gen Rep):22–30
35. Koopmans W, Woon ST, Brooks AE, Dunbar PR, Browett P, Ameratunga R (2013) Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). J Clin Immunol 33(1):68–73